DEXWireNews
Premium
About me
Official TradingView Page for www.DEXWireNews.com. Since 2009, we are the #1 Source For #FREE Winning #NASDAQ & #NYSE-Listed Alerts! 🤑💰💵📈
The company just announced that the final patient in its Phase 3 clinical trial evaluating RP-G28 for the potential treatment of lactose intolerance has completed the 30-day treatment period. Topline data should be available in early Q4. Look for continuation tomorrow, huge potential gains. Company Description Ritter Pharmaceuticals, Inc. engages in the...
Very positive move today on a very negative day in the markets, 22% gains is significant in a stock with a history of extreme spikes in price and volume. We will look for continuation in the days to follow. Company Description ATA, Inc. engages in the provision of computer-based testing services. It serves professional licensure and certification tests in...
Appliance Recycling Centers of America, Inc. engages in the provision of turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs. It operates through the Recycling, and Technology segments. The Recycling segment focuses on turnkey appliance recycling program. The Technology segment develops technology to...
Set your alerts for this stock has a history of 100% spikes, price up premarket on no news? Moleculin Biotech, Inc. is a clinical stage pharmaceutical company, which focuses on the development of oncology drug candidates. Its Annamycin product candidate helps in the treatment of relapsed or refractory acute myeloid leukemia. The company's preclinical small...
Positive research results today could bring quite a spike in price and volume. OCALA, Fla., May 06, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases — and whose product portfolio includes...
$$$$$$$$$$$$$$$ BIG MOVER $$$$$$$$$$$$$$$$$$$$$$$ Aemetis India Plant Wins $23 Million Biodiesel Supply Contract with India State-Owned Oil Companies Company Description Aemetis, Inc. operates as a renewable fuels and biochemicals company. The firm focuses on the acquisition, development, and commercialization of technologies that replace traditional...
After a fantastic few days for Crypto things have stalled somewhat. BTC was the Bull of the week while BCH didn't quite get back to the highs from early April. We have a possible bull flag forming which would give a substantial move to the market, possibly in the next 2 days. We will keep a eye on indicators turning more positive and the BBands closing .
In the past month there has been a steady stream of positive news coming from Laredo Petroleum Inc, cost cutting measures, new Board appointments and improved efficiency have helped build investor confidence. On May 2nd results and earnings were very positive, with higher than expected production for a lower cost. Currently trading at very low P/E 2.13 this...
On the top of our watchlist for the next week, speculation is rife about merger next week. Trade setup as per the chart. AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include...
Expectations are so low for Weight watchers and negativity is at a all time high,so it may just be the perfect conditions for a nice pop in earnings. Any good news what so ever will have a very positive effect on investor sentiment. This is a risky long but placing our stop lose on support offers a good RR on the trade. If the trade would happen to go against us...
On the 30th April Fuelcell Energy announced a new project which sent the stock 20% higher, we are looking for continuation in the name which has really been beaten down. Cash concerns have inflicted a lot of skepticism on the company but several Institutional investors have recently added to their positions in the stock. Blackrock added 10.5% to their position in...
Medicine Man Technologies is a fully integrated operator in the cannabis industry, offering consulting, cultivation supplies and equipment, retail pharma-grade products, and turnkey solutions for cannabis producers, processors and retailers for nearly a decade. Medicine Man Technologies is leveraging its expertise and intellectual property to vertically integrate...
This is purely on our watch-list for continuation of the buying activity already taken place, on news of restructuring within the company. Emerge Energy Services LP engages in the ownership, operation, acquisition and development of a diversified portfolio of energy service assets. It also engages in the businesses of mining, processing, and distributing silica...
Sentiment has been very positive in ALDEYRA THERAPEUTICS having already released positive results for other pipeline drugs. On may 1st phase 2 results for its new Dry Eye Syndrome drug will be presented and optimism is high on the rumor mill. The current price target by 7 analysts covering the name is $31 which is considerable higher than current levels....
Interest in Silk Road Medical will be sure to intensify this week as news-flow is expected. Since the IPO, buying has continued in the name and analysts interest will increase the volume and bullish sentiment. We see this as a great company with huge opportunity. Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE...
This chart and the price action is a thing of beauty. The price had a break above resistance and has now tested that level on multiple occasions before continuing higher. We foresee a breakout from the pennant in the near future possibly on earnings, in our opinion the chart is extremely bullish. Currently 5 analysts cover the company and have a average price...
Over the past month few months speculation and accumulation in CFMS has drawn out attention. Conformis, Inc is a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting...
Don't worry that you missed out on this initial move in the price, still plenty of room to run for ZYNERBA PHARMA, which specializes in the development and commercialism of cannabis treatments for conditions ranging from Epilepsy and Osteoarthritis. Although the stock has had a considerable move this month, it is still a low cap company with huge potential, so...
